These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18800767)

  • 41. American Chemical Society--234th National Meeting. Syntheses of novel compounds and data on novel therapeutics. 19-23 August 2007, Boston, MA, USA.
    Rotella D
    IDrugs; 2007 Oct; 10(10):681-5. PubMed ID: 17899481
    [No Abstract]   [Full Text] [Related]  

  • 42. Synthesis and Structure-Activity Relationships of N-Dihydrocoptisine-8-ylidene Aromatic Amines and N-Dihydrocoptisine-8-ylidene Aliphatic Amides as Antiulcerative Colitis Agents Targeting XBP1.
    Xie M; Zhang HJ; Deng AJ; Wu LQ; Zhang ZH; Li ZH; Wang WJ; Qin HL
    J Nat Prod; 2016 Apr; 79(4):775-83. PubMed ID: 26981782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear receptors: old targets, new opportunities.
    Asadullah K; Metternich R
    Curr Drug Targets Inflamm Allergy; 2004 Dec; 3(4):333-4. PubMed ID: 15587503
    [No Abstract]   [Full Text] [Related]  

  • 44. Nuclear magnetic resonance spectra of amines. I. Identification of N-methyl tertiary amines.
    Thompson WE; Warren RJ; Zarembo JE; Eisdorfer IB
    J Pharm Sci; 1966 Jan; 55(1):110-1. PubMed ID: 5918637
    [No Abstract]   [Full Text] [Related]  

  • 45. Liver X receptors in lipid metabolism: opportunities for drug discovery.
    Hong C; Tontonoz P
    Nat Rev Drug Discov; 2014 Jun; 13(6):433-44. PubMed ID: 24833295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of LXR controls the polarization of human inflammatory macrophages through upregulation of MAFB.
    de la Aleja AG; Herrero C; Torres-Torresano M; Schiaffino MT; Del Castillo A; Alonso B; Vega MA; Puig-Kröger A; Castrillo A; Corbí ÁL
    Cell Mol Life Sci; 2023 Mar; 80(4):96. PubMed ID: 36930354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR.
    Zheng W; Lu Y; Tian S; Ma F; Wei Y; Xu S; Li Y
    J Biol Chem; 2018 Aug; 293(32):12535-12541. PubMed ID: 29934308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.
    Fessler MB
    Pharmacol Ther; 2018 Jan; 181():1-12. PubMed ID: 28720427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ligands of Therapeutic Utility for the Liver X Receptors.
    Komati R; Spadoni D; Zheng S; Sridhar J; Riley KE; Wang G
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28067791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators.
    Nomura S; Endo-Umeda K; Aoyama A; Makishima M; Hashimoto Y; Ishikawa M
    ACS Med Chem Lett; 2015 Aug; 6(8):902-7. PubMed ID: 26288691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification at the Lipophilic Domain of RXR Agonists Differentially Influences Activation of RXR Heterodimers.
    Ohsawa F; Morishita K; Yamada S; Makishima M; Kakuta H
    ACS Med Chem Lett; 2010 Dec; 1(9):521-5. PubMed ID: 24900241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
    Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA.
    Lou X; Toresson G; Benod C; Suh JH; Philips KJ; Webb P; Gustafsson JA
    Nat Struct Mol Biol; 2014 Mar; 21(3):277-81. PubMed ID: 24561505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microwave assisted synthesis of novel pyrazolone derivatives attached to a pyrimidine moiety and evaluation of their anti-inflammatory, analgesic and antipyretic activities.
    Antre RV; Cendilkumar A; Goli D; Andhale GS; Oswal RJ
    Saudi Pharm J; 2011 Oct; 19(4):233-43. PubMed ID: 23960764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear receptors and their selective pharmacologic modulators.
    Burris TP; Solt LA; Wang Y; Crumbley C; Banerjee S; Griffett K; Lundasen T; Hughes T; Kojetin DJ
    Pharmacol Rev; 2013 Apr; 65(2):710-78. PubMed ID: 23457206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of novel liver X receptor activators by structure-based modeling.
    von Grafenstein S; Mihaly-Bison J; Wolber G; Bochkov VN; Liedl KR; Schuster D
    J Chem Inf Model; 2012 May; 52(5):1391-400. PubMed ID: 22489742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The retinoid X receptors and their ligands.
    Dawson MI; Xia Z
    Biochim Biophys Acta; 2012 Jan; 1821(1):21-56. PubMed ID: 22020178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NF-kappaB signaling: multiple angles to target OA.
    Marcu KB; Otero M; Olivotto E; Borzi RM; Goldring MB
    Curr Drug Targets; 2010 May; 11(5):599-613. PubMed ID: 20199390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response.
    Venteclef N; Jakobsson T; Ehrlund A; Damdimopoulos A; Mikkonen L; Ellis E; Nilsson LM; Parini P; Jänne OA; Gustafsson JA; Steffensen KR; Treuter E
    Genes Dev; 2010 Feb; 24(4):381-95. PubMed ID: 20159957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.